Thrombocytosis as a prognostic marker in gastrointestinal cancers  

作　　者：Ioannis A Voutsadakis 

机构地区：[1]Division of Medical Oncology,Sault Area Hospital

出　　处：《World Journal of Gastrointestinal Oncology》2014年第2期34-40,共7页世界胃肠肿瘤学杂志（英文版）（电子版）

摘　　要：Thrombocytosis is an adverse prognostic factor in many types of cancer. These include breast cancer, ovarian and other gynecologic cancers, renal cell carcinoma and lung cancers. In gastrointestinal cancers of various locations and histologic types, thrombocytosis has been reported in general to be associated with adverse clinical outcomes. Platelet count measurement is well standardized and available in every clinical laboratory, making its use as a prognostic marker practical. This paper will discuss the data on the prognostic value of thrombocytosis in gastrointestinal cancers as well as pathogenic aspects of the association that strengthen the case for its use in clinical prognostication.Thrombocytosis is an adverse prognostic factor in many types of cancer. These include breast cancer, ovarian and other gynecologic cancers, renal cell carcinoma and lung cancers. In gastrointestinal cancers of various locations and histologic types, thrombocytosis has been reported in general to be associated with adverse clinical outcomes. Platelet count measurement is well standardized and available in every clinical laboratory, making its use as a prognostic marker practical. This paper will discuss the data on the prognostic value of thrombocytosis in gastrointestinal cancers as well as pathogenic aspects of the association that strengthen the case for its use in clinical prognostication.

关 键 词：THROMBOCYTOSIS PLATELETS CANCER Gastroin-testinal PROGNOSIS 

分 类 号：R735[医药卫生—肿瘤]